Order Article Reprints

Maddaloni M, Farra R, Dapas B, Felluga F, Benedetti F, Berti F, Drioli S, Vidali M, Cemazar M, Kamensek U, et al. In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Pharmaceutics. 2024; 16(5):664. https://doi.org/10.3390/pharmaceutics16050664

Maddaloni, Marianna, Rossella Farra, Barbara Dapas, Fulvia Felluga, Fabio Benedetti, Federico Berti, Sara Drioli, Mattia Vidali, Maja Cemazar, Urska Kamensek, and et al. 2024. "In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells" Pharmaceutics 16, no. 5: 664. https://doi.org/10.3390/pharmaceutics16050664

Maddaloni, M., Farra, R., Dapas, B., Felluga, F., Benedetti, F., Berti, F., Drioli, S., Vidali, M., Cemazar, M., Kamensek, U., Brancolini, C., Murano, E., Maremonti, F., Grassi, M., Biasin, A., Rizzolio, F., Cavarzerani, E., Scaggiante, B., Bulla, R., ... Grassi, G. (2024). In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells. Pharmaceutics, 16(5), 664. https://doi.org/10.3390/pharmaceutics16050664